U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07117110) titled 'Lycopene as a Dietary Compliance Biomarker' on July 25.
Brief Summary: Rationale: To determine the plasma lycopene concentration before and after an oral intake of lycopene in order to use this measurement as a life style compliance marker.
Objective: Primary objective: to determine if a plasma lycopene concentration can serve as a response parameter after a single dose of dietary lycopene.
Study design: Cross-over interventional pilot study.
Study population: Ten male healthy volunteers 18-75 years. Intervention: Oral food supplement tablet 40 mg lycopene once, versus oral soup of cooked tomatoes equivalent to 40 mg lycopene con...